Dentists in Emmett, ID Accepting Medicare
8 Dentists found. Showing 1 - 8
 Dr. Jimmy Joe Zarybnisky, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2003 S Plaza Rd, Emmett, ID 83617 Phone: 208-365-3534 |
Dr. Shon Dewane Rooks, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1110 S Washington Ave, Emmett, ID 83617 Phone: 208-365-3860 |
Dr. Clark Richard Elkins, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1110 S Washington Ave, Emmett, ID 83617 Phone: 208-963-0055 |
Kelsey Peterson, DMD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1312 South Washington Street, Emmett, ID 83617 Phone: 208-941-6640 |
Dr. Warren Richard Willis, D.M.D Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 119 N Wardwell Ave, Emmett, ID 83617 Phone: 208-365-6313 Fax: 208-365-1303 |
Jeffrey L Henken, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1020 E Locust, Emmett, ID 83617 Phone: 208-365-5064 Fax: 208-365-4235 |
Darren K Wallace, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2003 E Quail Run Rd, Emmett, ID 83617 Phone: 208-365-3534 Fax: 208-365-6231 |
 Mrs. Andrea L Wallace, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2003 S Plaza Rd, Emmett, ID 83617 Phone: 208-365-3534 Fax: 208-365-6231 |
News Archive
Winston announces Phase II study results of Dolorac for chronic migraine at Lazard Conference
Winston Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing and commercializing novel pain management therapies, announced the results of its Phase II study on its patented Dolorac Nasal Solution (doxepin 0.4%) for prophylaxis of chronic migraine at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
Carotid endarterectomy versus carotid stenting for clogged neck arteries
Like horses running down the long stretch of a race track, two different artery-opening treatments appear to be running neck-and-neck when it comes to preventing stroke among people with clogged neck arteries and other health problems.
Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer
Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.
Researchers gain new insight on immune cells that harbor latent HIV virus
Drugs for HIV have become adept at suppressing infection, but they still can't eliminate it. That's because the medication in these pills doesn't touch the virus' hidden reserves, which lie dormant within infected white blood cells. Unlock the secrets of this pool of latent virus, scientists believe, and it may become possible to cure - not just control - HIV.
Radiotherapy needs likely to increase in all European countries by 2025
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology.
› Verified 5 days ago
Counselors
Clinical Social Workers
Dentists
Pharmacists
Occupational Therapists
Psychologists